Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Lipid Disorder Treatment Market Size Shifted, And What Is the Outlook Through 2034?
The market for treating lipid disorders has seen a significant expansion over the past few years. It’s projected to increase from $10.69 billion in 2024 to $12.06 billion in 2025, representing a compound annual growth rate (CAGR) of 12.9%. The historical growth is due to factors such as the rising acceptance of a sedentary lifestyle, growth in the working-class population, heightened awareness about the condition and its therapies, an increase in desk jobs, and the growing incidence of familial combined hyperlipidemia.
The market for treating lipid disorders is projected to experience rapid expansion in the forthcoming years, swelling to$18.82 billion in 2029″ with a compound annual growth rate (CAGR) of 11.8%. This surge during the forecast period can be ascribed to the escalating instances of obesity and high cholesterol, the rising prevalence of heart diseases, increased cases of high cholesterol leading to cardiovascular conditions, and the heightened demand for efficient and safe treatments, such as those needed due to excessive intake of alcohol and smoking. Significant trends in the forecast period comprise of advances in pharmaceutical technology, product innovation, an escalation in business expansion investments, treatments being enhanced by technological advancements, and clinical advancements.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15600&type=smp
Which Primay Drivers Are Accelerating Growth in the Lipid Disorder Treatment Market?
Increasing incidences of obesity and high cholesterol are projected to spur the expansion of the lipid disorder treatment market in the coming years. Obesity signifies an undue accumulation of body fat, and high cholesterol denotes excessive cholesterol content in the bloodstream, both of which can lead to serious health problems. Factors such as unhealthy eating habits, inactive lifestyles, genetics, and environmental impacts contribute to the rise of obesity and high cholesterol. The significance of lipid disorder treatment is accentuated due to its effectiveness in managing obesity and high cholesterol through a blend of drug therapies, lifestyle changes, weight management techniques, patient awareness programs, and holistic healthcare. For example, as per the World Obesity Atlas 2022 published in May 2022 by the UK’s World Obesity Federation, a non-profit organization, by 2030, obesity will affect one billion people worldwide including one in every five women and one in every seven men. By 2035, this figure is projected to reach four billion or 51% of the world’s population. Hence, the escalating instances of obesity and high cholesterol significantly contribute to the lipid disorder treatment market’s growth.
Which Primary Segments of the Lipid Disorder Treatment Market Are Driving Growth and Industry Transformations?
The lipid disorder treatmentmarket covered in this report is segmented –
1) By Drug Type: Atorvastatin; Fluvastatin; Rosuvastatin; Simvastatin; Pravastatin; Other Drugs
2) By Indication: Familial Combined Hyperlipidemia; Familial Defective Apolipoprotein B-100; Familial Dysbetalipoproteinemia; Familial Hypertriglyceridemia; Heterozygous Familial Hypercholesterolemia; Other Indications
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Atorvastatin: Generic Atorvastatin; Brand-Name Atorvastatin ( Lipitor)
2) By Fluvastatin: Generic Fluvastatin; Brand-Name Fluvastatin ( Lescol)
3) By Rosuvastatin: Generic Rosuvastatin; Brand-Name Rosuvastatin ( Crestor)
4) By Simvastatin: Generic Simvastatin; Brand-Name Simvastatin ( Zocor)
5) By Pravastatin: Generic Pravastatin; Brand-Name Pravastatin ( Pravachol)
6) By Other Drugs: Ezetimibe; Pcsk9 Inhibitors ( Alirocumab, Evolocumab); Fibrates ( Gemfibrozil, Fenofibrate); Niacin (Vitamin B3); Omega-3 Fatty Acids ( Icosapent Ethyl)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15600&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Lipid Disorder Treatment Market?# Market?
North America was the largest region in the lipid disorder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Lipid Disorder Treatment Industry Dynamics?
Significant businesses in the lipid disorder treatment market are evolving the proprotein convertase subtilisin type 9 (PCSK9) inhibitors to provide enhanced and specialized therapies for the management of elevated cholesterol levels. By improving the removal of LDL cholesterol from the bloodstream, PCSK9 inhibitors help in controlling lipid disorders and decreasing the chances of cardiovascular diseases in patients who are at high risk. For instance, in March 2024, Praluent (alirocumab) injection, a product of the US biotech firm Regeneron Pharmaceuticals Inc., received approval from the U.S. Food and Drug Administration (FDA) for its use in treating heterozygous familial hypercholesterolemia (HeFH) in children aged 8 years and older. The special aspect of the Praluent injection is its ability to prevent the binding of PCSK9 to the LDL receptor, increasing the amount of LDL receptors on the surfaces of liver cells, and consequently aiding in LDL removal and lowering LDL-C levels in the bloodstream.
View the full report here:
https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report
What Parameters Are Used to Define the Lipid Disorder Treatment Market?
Lipid disorder treatment refers to a comprehensive approach that includes lifestyle modifications, medications, and regular monitoring to manage conditions like high cholesterol and triglycerides. It aims to reduce the risk of atherosclerosis and its complications, such as heart disease and stroke.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15600
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model